questionsmedicales.fr
Maladies du système stomatognathique
Maladies des dents
Hypercémentose
Hypercémentose : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Hypercementose
Radiographie dentaire
Examen clinique
Hypercementose
Radiographie dentaire
Hypercementose
Hypercementose
Symptômes dentaires
Maladies parodontales
Hypercementose
Symptômes
5
Hypercementose
Douleur dentaire
Hypercementose
Douleur dentaire
Hypercementose
Examen clinique
Hypercementose
Fonction masticatoire
Prévention
5
Hygiène bucco-dentaire
Prévention dentaire
Visite dentaire
Hypercementose
Alimentation saine
Santé dentaire
Orthodontie
Hypercementose
Traitements
5
Hypercementose
Traitement dentaire
Hypercementose
Médicaments anti-inflammatoires
Chirurgie dentaire
Hypercementose
Suivi médical
Hypercementose
Prévention dentaire
Hypercementose
Complications
5
Complications dentaires
Hypercementose
Infection dentaire
Hypercementose
Perte dentaire
Hypercementose
Santé générale
Hypercementose
Douleur chronique
Hypercementose
Facteurs de risque
5
Facteurs de risque
Hypercementose
Maladies systémiques
Hypercementose
Antécédents familiaux
Hypercementose
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Hypercémentose : Questions médicales les plus fréquentes",
"headline": "Hypercémentose : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Hypercémentose : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-13",
"dateModified": "2025-04-08",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Hypercémentose"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Maladies des dents",
"url": "https://questionsmedicales.fr/mesh/D014076",
"about": {
"@type": "MedicalCondition",
"name": "Maladies des dents",
"code": {
"@type": "MedicalCode",
"code": "D014076",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C07.793"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Hypercémentose",
"alternateName": "Hypercementosis",
"code": {
"@type": "MedicalCode",
"code": "D006936",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Kamil Górski",
"url": "https://questionsmedicales.fr/author/Kamil%20G%C3%B3rski",
"affiliation": {
"@type": "Organization",
"name": "Department of Large Animal Diseases and Clinic, Institute of Veterinary Medicine, Warsaw University of Life Sciences, 02-787 Warsaw, Poland."
}
},
{
"@type": "Person",
"name": "Izabela Polkowska",
"url": "https://questionsmedicales.fr/author/Izabela%20Polkowska",
"affiliation": {
"@type": "Organization",
"name": "Department and Clinic of Animal Surgery, Faculty of Veterinary Medicine, University of Life Sciences, 20-950 Lublin, Poland."
}
},
{
"@type": "Person",
"name": "Bernard Turek",
"url": "https://questionsmedicales.fr/author/Bernard%20Turek",
"affiliation": {
"@type": "Organization",
"name": "Department of Large Animal Diseases and Clinic, Institute of Veterinary Medicine, Warsaw University of Life Sciences, 02-787 Warsaw, Poland."
}
},
{
"@type": "Person",
"name": "Andrzej Bereznowski",
"url": "https://questionsmedicales.fr/author/Andrzej%20Bereznowski",
"affiliation": {
"@type": "Organization",
"name": "Division of Veterinary Epidemiology and Economics, Institute of Veterinary Medicine, Warsaw University of Life Sciences, Nowoursynowska 159c, 02-776 Warsaw, Poland."
}
},
{
"@type": "Person",
"name": "Bruno Maureille",
"url": "https://questionsmedicales.fr/author/Bruno%20Maureille",
"affiliation": {
"@type": "Organization",
"name": "Univ. Bordeaux, CNRS, Ministère de la Culture, PACEA, UMR 5199, F-33600 Pessac, France."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Serum prostate specific antigen is a good indicator of prostatic volume in men with benign prostatic hyperplasia.",
"datePublished": "2022-12-15",
"url": "https://questionsmedicales.fr/article/36546488",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.4102/phcfm.v14i1.3736"
}
},
{
"@type": "ScholarlyArticle",
"name": "Granulomatous prostatitis: mimicking locally advanced prostate adenocarcinoma.",
"datePublished": "2023-10-17",
"url": "https://questionsmedicales.fr/article/37850783",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.23750/abm.v94i5.13751"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prostatic Artery Embolization Versus Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia: A Cost-Effectiveness Analysis.",
"datePublished": "2022-08-12",
"url": "https://questionsmedicales.fr/article/35964881",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jvir.2022.08.006"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prostate organogenesis.",
"datePublished": "2022-06-21",
"url": "https://questionsmedicales.fr/article/35726824",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1242/dev.200394"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prostatic Urethral Length as a Predictor for Surgery in Benign Prostatic Hyperplasia.",
"datePublished": "2023-03-10",
"url": "https://questionsmedicales.fr/article/36974872",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.33314/jnhrc.v20i3.4613"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies du système stomatognathique",
"item": "https://questionsmedicales.fr/mesh/D009057"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies des dents",
"item": "https://questionsmedicales.fr/mesh/D014076"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hypercémentose",
"item": "https://questionsmedicales.fr/mesh/D006936"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Hypercémentose - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Hypercémentose",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-11",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Hypercémentose",
"description": "Comment diagnostiquer l'hypercémentose ?\nQuels examens sont nécessaires pour confirmer l'hypercémentose ?\nQuels signes radiographiques indiquent l'hypercémentose ?\nL'hypercémentose est-elle visible à l'œil nu ?\nPeut-on confondre l'hypercémentose avec d'autres conditions ?",
"url": "https://questionsmedicales.fr/mesh/D006936?mesh_terms=Prostate#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Hypercémentose",
"description": "Quels sont les symptômes de l'hypercémentose ?\nL'hypercémentose provoque-t-elle des douleurs ?\nY a-t-il des signes cliniques visibles ?\nL'hypercémentose affecte-t-elle la mastication ?\nPeut-on avoir des gencives enflammées avec l'hypercémentose ?",
"url": "https://questionsmedicales.fr/mesh/D006936?mesh_terms=Prostate#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Hypercémentose",
"description": "Comment prévenir l'hypercémentose ?\nLes visites chez le dentiste aident-elles à prévenir l'hypercémentose ?\nUne alimentation saine peut-elle prévenir l'hypercémentose ?\nLe tabagisme influence-t-il l'hypercémentose ?\nLes traitements orthodontiques affectent-ils l'hypercémentose ?",
"url": "https://questionsmedicales.fr/mesh/D006936?mesh_terms=Prostate#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Hypercémentose",
"description": "Quel traitement est recommandé pour l'hypercémentose ?\nDes médicaments sont-ils nécessaires pour l'hypercémentose ?\nQuand faut-il envisager une intervention chirurgicale ?\nL'hypercémentose nécessite-t-elle un suivi régulier ?\nPeut-on prévenir l'hypercémentose par des soins dentaires ?",
"url": "https://questionsmedicales.fr/mesh/D006936?mesh_terms=Prostate#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Hypercémentose",
"description": "Quelles complications peuvent survenir avec l'hypercémentose ?\nL'hypercémentose peut-elle entraîner des infections ?\nPeut-on perdre des dents à cause de l'hypercémentose ?\nL'hypercémentose affecte-t-elle la santé générale ?\nDes douleurs chroniques peuvent-elles résulter de l'hypercémentose ?",
"url": "https://questionsmedicales.fr/mesh/D006936?mesh_terms=Prostate#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Hypercémentose",
"description": "Quels sont les facteurs de risque de l'hypercémentose ?\nL'âge influence-t-il le risque d'hypercémentose ?\nLes maladies systémiques augmentent-elles le risque ?\nLe stress a-t-il un impact sur l'hypercémentose ?\nLes antécédents familiaux jouent-ils un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D006936?mesh_terms=Prostate#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer l'hypercémentose ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par radiographies dentaires montrant un épaississement du ciment."
}
},
{
"@type": "Question",
"name": "Quels examens sont nécessaires pour confirmer l'hypercémentose ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des examens cliniques et des radiographies sont nécessaires pour évaluer l'état des dents."
}
},
{
"@type": "Question",
"name": "Quels signes radiographiques indiquent l'hypercémentose ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "On observe un épaississement du cimentum sur les radiographies, souvent autour des racines."
}
},
{
"@type": "Question",
"name": "L'hypercémentose est-elle visible à l'œil nu ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, elle nécessite des radiographies pour être détectée, car elle est asymptomatique au début."
}
},
{
"@type": "Question",
"name": "Peut-on confondre l'hypercémentose avec d'autres conditions ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut être confondue avec d'autres maladies parodontales, nécessitant un diagnostic précis."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes de l'hypercémentose ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hypercémentose est souvent asymptomatique, mais peut causer des douleurs dentaires dans certains cas."
}
},
{
"@type": "Question",
"name": "L'hypercémentose provoque-t-elle des douleurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle est généralement asymptomatique, mais des douleurs peuvent survenir si des complications se développent."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes cliniques visibles ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'y a pas de signes cliniques visibles, mais des radiographies peuvent montrer des anomalies."
}
},
{
"@type": "Question",
"name": "L'hypercémentose affecte-t-elle la mastication ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "En général, elle n'affecte pas la mastication, sauf si elle entraîne des complications dentaires."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des gencives enflammées avec l'hypercémentose ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hypercémentose elle-même ne cause pas d'inflammation des gencives, mais des maladies parodontales peuvent coexister."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'hypercémentose ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir une bonne hygiène bucco-dentaire et consulter régulièrement un dentiste aide à prévenir."
}
},
{
"@type": "Question",
"name": "Les visites chez le dentiste aident-elles à prévenir l'hypercémentose ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des visites régulières permettent de détecter précocement les problèmes dentaires et d'agir."
}
},
{
"@type": "Question",
"name": "Une alimentation saine peut-elle prévenir l'hypercémentose ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée contribue à la santé dentaire, mais ne prévient pas spécifiquement l'hypercémentose."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il l'hypercémentose ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabagisme peut aggraver les problèmes parodontaux, augmentant le risque d'hypercémentose."
}
},
{
"@type": "Question",
"name": "Les traitements orthodontiques affectent-ils l'hypercémentose ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements orthodontiques peuvent parfois exacerber l'hypercémentose, nécessitant une surveillance."
}
},
{
"@type": "Question",
"name": "Quel traitement est recommandé pour l'hypercémentose ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement dépend des symptômes; souvent, aucune intervention n'est nécessaire si asymptomatique."
}
},
{
"@type": "Question",
"name": "Des médicaments sont-ils nécessaires pour l'hypercémentose ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Généralement, aucun médicament n'est requis, sauf en cas de douleur ou d'infection associée."
}
},
{
"@type": "Question",
"name": "Quand faut-il envisager une intervention chirurgicale ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une intervention chirurgicale est rare et envisagée uniquement si des complications graves surviennent."
}
},
{
"@type": "Question",
"name": "L'hypercémentose nécessite-t-elle un suivi régulier ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi régulier est conseillé pour surveiller l'évolution et prévenir d'éventuelles complications."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir l'hypercémentose par des soins dentaires ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des soins dentaires réguliers peuvent aider à prévenir les maladies parodontales qui aggravent l'hypercémentose."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec l'hypercémentose ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des douleurs dentaires, des infections ou des problèmes de mastication."
}
},
{
"@type": "Question",
"name": "L'hypercémentose peut-elle entraîner des infections ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, si elle est associée à des maladies parodontales, le risque d'infection augmente."
}
},
{
"@type": "Question",
"name": "Peut-on perdre des dents à cause de l'hypercémentose ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Indirectement, si elle est associée à des maladies parodontales, cela peut entraîner une perte dentaire."
}
},
{
"@type": "Question",
"name": "L'hypercémentose affecte-t-elle la santé générale ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "En général, l'hypercémentose n'affecte pas la santé générale, mais des complications dentaires peuvent avoir un impact."
}
},
{
"@type": "Question",
"name": "Des douleurs chroniques peuvent-elles résulter de l'hypercémentose ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des douleurs chroniques peuvent survenir si des complications dentaires se développent."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque de l'hypercémentose ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des maladies parodontales, des traitements orthodontiques et le tabagisme."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque d'hypercémentose ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque d'hypercémentose augmente avec l'âge en raison de l'usure dentaire et des maladies parodontales."
}
},
{
"@type": "Question",
"name": "Les maladies systémiques augmentent-elles le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines maladies systémiques, comme le diabète, peuvent augmenter le risque d'hypercémentose."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur l'hypercémentose ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress peut contribuer à des comportements nuisibles pour la santé dentaire, augmentant le risque."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de problèmes dentaires peuvent augmenter le risque d'hypercémentose."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 08/04/2025
Contenu vérifié selon les dernières recommandations médicales
4 publications dans cette catégorie
Affiliations :
Department of Large Animal Diseases and Clinic, Institute of Veterinary Medicine, Warsaw University of Life Sciences, 02-787 Warsaw, Poland.
Publications dans "Hypercémentose" :
4 publications dans cette catégorie
Affiliations :
Department and Clinic of Animal Surgery, Faculty of Veterinary Medicine, University of Life Sciences, 20-950 Lublin, Poland.
Publications dans "Hypercémentose" :
4 publications dans cette catégorie
Affiliations :
Department of Large Animal Diseases and Clinic, Institute of Veterinary Medicine, Warsaw University of Life Sciences, 02-787 Warsaw, Poland.
Publications dans "Hypercémentose" :
4 publications dans cette catégorie
Affiliations :
Division of Veterinary Epidemiology and Economics, Institute of Veterinary Medicine, Warsaw University of Life Sciences, Nowoursynowska 159c, 02-776 Warsaw, Poland.
Publications dans "Hypercémentose" :
3 publications dans cette catégorie
Affiliations :
Univ. Bordeaux, CNRS, Ministère de la Culture, PACEA, UMR 5199, F-33600 Pessac, France.
Publications dans "Hypercémentose" :
3 publications dans cette catégorie
Affiliations :
Institute of Biomedical Engineering, Faculty of Mechanical Engineering, Białystok University of Technology, 15-351 Bialystok, Poland.
Publications dans "Hypercémentose" :
3 publications dans cette catégorie
Affiliations :
Department of Large Animal Diseases and Clinic, Institute of Veterinary Medicine, Warsaw University of Life Sciences, 02-787 Warsaw, Poland.
Publications dans "Hypercémentose" :
3 publications dans cette catégorie
Affiliations :
Department of Large Animal Diseases and Clinic, Institute of Veterinary Medicine, Warsaw University of Life Sciences, 02-787 Warsaw, Poland.
Publications dans "Hypercémentose" :
2 publications dans cette catégorie
Affiliations :
Univ. Bordeaux, CNRS, Ministère de la Culture, PACEA, UMR 5199, F-33600 Pessac, France; Univ. de Bordeaux, UFR des Sciences Odontologiques de Bordeaux, Bordeaux, France; CHU de Bordeaux, Bordeaux, France. Electronic address: lea.masse@u-bordeaux.fr.
Publications dans "Hypercémentose" :
2 publications dans cette catégorie
Affiliations :
Univ. Bordeaux, CNRS, Ministère de la Culture, PACEA, UMR 5199, F-33600 Pessac, France; Department of Human Evolution, Max Planck Institute for Evolutionary Anthropology, Deutscher Platz 6, 04103 Leipzig, Germany.
Publications dans "Hypercémentose" :
2 publications dans cette catégorie
Affiliations :
Faculty of Veterinary Medicine, Institute of Veterinary-Anatomy, -Histology and -Embryology, Justus-Liebig-University Gießen, Gießen, Germany.
Publications dans "Hypercémentose" :
2 publications dans cette catégorie
Affiliations :
Clinic for Horses, University of Veterinary Medicine Hannover, Foundation, Hannover, Germany.
Publications dans "Hypercémentose" :
1 publication dans cette catégorie
Affiliations :
Australian Veterinary Equine Dentistry Pty Ltd, Clayfield, Queensland, Australia.
Publications dans "Hypercémentose" :
1 publication dans cette catégorie
Publications dans "Hypercémentose" :
1 publication dans cette catégorie
Publications dans "Hypercémentose" :
1 publication dans cette catégorie
Publications dans "Hypercémentose" :
1 publication dans cette catégorie
Publications dans "Hypercémentose" :
1 publication dans cette catégorie
Publications dans "Hypercémentose" :
1 publication dans cette catégorie
Affiliations :
Northeast Equine Veterinary Dental Services, LLC, PO Box 264, Topsfield, MA 01983, USA. Electronic address: leahlimonedvm@gmail.com.
Publications dans "Hypercémentose" :
1 publication dans cette catégorie
Affiliations :
Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, 930 Campus Rd, Ithaca, NY, 14850, USA. aw656@cornell.edu.
Publications dans "Hypercémentose" :
Benign prostatic hyperplasia (BPH) is the most common cause of bladder outlet obstruction in men over the age of 50 years. An association between the prostate specific antigen (PSA), International Pro...
To determine the correlation between the PSA, IPSS and PV in men of African descent....
This was a cross sectional analysis involving 92 patients diagnosed as having symptomatic BPH at the Ho Teaching Hospital....
The data were collected using standardised questionnaires. The IPSS determined urinary symptom severity. The PV was determined using a transabdominal ultrasound machine. Serum PSA was retrieved from t...
The mean PV was 61.04 cm3 ± 21.95 cm3, the mean PSA was 4.21 ng/mL ± 3.85 ng/mL, and mean IPSS of 21.59 ± 3.78. The Pearson's correlation between PV and PSA was 0.283 (p = 0.01), between PV and IPSS w...
This study showed that serum PSA has a positive correlation with PV. However, IPSS had no significant association with PSA or PV in patients with BPH.Contribution: This study provides insights into th...
We report the case of a 63-year-old male who came to the urology clinic with an increasing value of the prostate specific antigen and an asymmetrical enlargement at the digital rectal examination. The...
To compare the cost effectiveness of prostatic artery embolization (PAE) with that of transurethral resection of the prostate (TURP) for the treatment of medically refractory benign prostatic hyperpla...
A cost-effectiveness analysis with Markov modeling was performed, comparing the clinical course after PAE with that after TURP for 3 years. Probabilities were obtained from the available literature, a...
Base case calculation showed comparable outcomes (PAE, 2.845 QALY; TURP, 2.854 QALY), with a cost difference of $3,104 (PAE, $2,934; TURP, $6,038). The incremental cost-effectiveness ratio was $360,24...
PAE is a cost-effective strategy to treat medically refractory BPH, resulting in comparable health benefits at a lower cost than that of TURP even when accounting for extreme alterations in adverse ev...
Prostate organogenesis begins during embryonic development and continues through puberty when the prostate becomes an important exocrine gland of the male reproductive system. The specification and gr...
Benign prostatic hyperplasia is associated with structural and morphological changes including elongation of prostatic urethral length. The aim of our study was to assess whether prostatic urethral le...
This prospective observational study was conducted over a 12-months duration. All the patients who presented with lower urinary tract symptoms secondary to benign prostatic hyperplasia were evaluated ...
A total of 153 patients were included in the study. Eighty-three (54.2%) patients underwent surgery during the study period. Prostate volume, intravesical prostatic protrusion, post-void residual volu...
BPH patients with longer PUL may require surgical management. PUL measured by TRUS may be a predicting factor for the need of surgery in BPH Keywords: Benign prostatic hyperplasia; lower urinary tract...
Biomarkers of DNA damage repair deficiency provide opportunities for personalized treatment with immunotherapy. However, there is limited research on the immune microenvironment of adeno-neuroendocrin...
A retrospective medical record review of 66 patients with prostate cancer (PCa) was performed. PCa samples from the 66 patients were analyzed using immunohistochemical staining for the detection of ch...
Twenty patients presented with adeno-NEPC, whereas 46 presented with adeno-PCa. The median age of patients at PCa diagnosis was 67.86 ± 7.05 years (68.65 ± 7.23 years, adeno-NEPC; 67.52 ± 7.02 years, ...
Our study revealed clinicopathological manifestations of adeno-NEPC and some possible predictive factors significantly associated with better outcomes in patients with adeno-NEPC. These findings might...
The purpose of the study was to evaluate the diagnostic significance of two new and a few clinical markers for prostate cancer (PCa) at various prostate volumes (PV)....
The study subjects were divided into two groups. Among them, there were 70 cases in the PV ≤30 ml group (benign prostatic hyperplasia [BPH]: 32 cases, PCa: 38 cases) and 372 cases in the PV > 30 ml gr...
In the PV ≤30 ml group, the diagnostic parameters based on prostate-specific antigen (PSA) had a decreased diagnostic significance for PCa. In the PV > 30 ml group, PSAD (AUC = 0.709), AVR (AVR = Age/...
Choosing appropriate indicators for different PVs could contribute to the early screening and diagnosis of PCa. The difference in the diagnostic value of two new indicators (A-PSAD and AVR), and PSAD ...
Holmium laser enucleation of the prostate (HoLEP) is a size-independent surgical option for treating benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS) with excellent, durable ...
This study aims to compare the ability of the PHI versus tPSA test to predict the presence of PCa in our population....
A prospective observational study was performed. We included patients with tPSA ≥ 2.5 ng/ml, biopsy naïve or previous negative biopsy, undergoing a blood test, which includes tPSA, fPSA, and p2PSA, an...
140 men were included. Fifty-seven (40.7%) had a positive prostate biopsy result (Group A), and 83 (59.3%) had a negative biopsy result (Group B). The mean age was similar in both groups (mean ± stand...
The PHI test improves PCa detection compared to tPSA in our population....
We compare Prostate Health Index, Prostate Health Index density, and PSA density in predicting clinically significant prostate cancer in MRI-guided prostate biopsy....
This is a multicenter evaluation of prospectively maintained prostate biopsy databases at 10 urology centers. Men with Prostate Health Index and MRI-guided targeted and systematic prostate biopsy perf...
A total of 1,215 men were analyzed. Prostate cancer and clinically significant prostate cancer were diagnosed in 51% (617/1,215) and 35% (422/1,215) of men, respectively. Clinically significant prosta...
Prostate Health Index density outperformed Prostate Health Index or PSA density in clinically significant prostate cancer detection in men with multiparametric MRI performed, and further reduced unnec...